CN Stock MarketDetailed Quotes

002100 Tecon Biology Co.Ltd

Watchlist
  • 6.82
  • +0.11+1.64%
Not Open Dec 2 15:00 CST
9.31BMarket Cap-31720P/E (TTM)

Tecon Biology Co.Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-5.06%3.65B
-25.54%2.86B
-31.02%2.68B
-15.00%2.82B
-35.08%3.84B
57.11%3.84B
67.53%3.89B
-3.05%3.32B
96.68%5.92B
37.29%2.45B
Transactional financial assets
--10.55M
-99.48%522.51K
--472.63K
-99.93%473.08K
----
--100M
----
--650.94M
----
----
Notes receivable and accounts receivable
-8.40%749.25M
-16.17%613.5M
-3.53%712.26M
7.93%430.75M
7.39%817.99M
33.91%731.84M
27.87%738.31M
26.94%399.1M
35.20%761.72M
17.61%546.5M
-Notes receivable
348.98%73.9M
-32.03%13.47M
67.52%26.64M
-11.60%9.62M
654.60%16.46M
306.30%19.82M
6.78%15.9M
30.07%10.88M
-79.03%2.18M
11.89%4.88M
-Accounts receivable
-15.74%675.36M
-15.73%600.02M
-5.09%685.63M
8.48%421.13M
5.53%801.54M
31.46%712.02M
28.43%722.41M
26.86%388.22M
37.35%759.54M
17.67%541.62M
Other receivables (including interest and dividends)
5.62%371.11M
-5.95%283.77M
-16.98%256M
-13.60%259.14M
3.05%351.37M
-2.96%301.73M
-17.93%308.36M
-8.72%299.94M
-14.27%340.97M
-18.31%310.92M
-Other receivable
----
-5.95%283.77M
----
----
----
-2.96%301.73M
----
-8.72%299.94M
----
-18.31%310.92M
Advance payment
131.55%862.5M
-20.41%316.22M
-27.30%484.52M
-65.96%386.57M
-52.75%372.48M
-23.27%397.31M
-24.24%666.45M
42.71%1.14B
13.60%788.37M
-23.40%517.77M
Inventories
-7.40%3B
-15.59%4.32B
-30.13%4.74B
-24.63%4.55B
-17.73%3.24B
-0.22%5.12B
16.73%6.78B
15.07%6.04B
30.87%3.93B
7.45%5.13B
Receivable financing
--11.28M
--2.29M
----
397.94%13.53M
----
----
----
1,371.03%2.72M
----
----
Other current assets
24.20%414.37M
2.55%483.24M
-19.20%479.93M
-11.04%475.88M
-17.10%333.62M
-4.24%471.21M
14.09%593.93M
7.35%534.95M
44.55%402.43M
35.72%492.07M
Total current assets
1.71%9.12B
-18.97%8.9B
-27.97%9.36B
-27.71%8.96B
-26.23%8.96B
16.21%10.98B
23.87%12.99B
16.81%12.4B
52.71%12.15B
11.36%9.45B
Non Current assets
Long-term equity investment
-13.59%33.56M
-12.16%33.83M
74.83%37.34M
-65.76%36.11M
-70.76%38.84M
-69.39%38.51M
-82.80%21.36M
-2.43%105.45M
10.88%132.83M
10.53%125.8M
Fixed assets
----
3.84%5.28B
----
----
----
3.70%5.08B
----
18.10%5.13B
----
28.09%4.9B
Constru in process
----
0.69%842.66M
----
----
----
86.76%836.88M
----
-52.47%425.14M
----
-42.20%448.09M
Productive biological assets
-22.75%280.75M
-19.38%292.7M
-22.07%295.55M
-10.65%320.76M
-5.62%363.42M
-17.58%363.08M
-7.13%379.26M
0.79%359M
14.20%385.07M
21.82%440.5M
Intangible assets
15.56%389.63M
13.12%385.71M
40.79%384.78M
34.44%360.84M
22.89%337.17M
22.06%340.96M
-2.63%273.3M
-1.36%268.4M
11.87%274.36M
11.73%279.34M
Development expenditure
-65.10%3.16M
-89.57%750K
-52.15%6.21M
-9.52%7.01M
-82.06%9.06M
-85.09%7.19M
-55.59%12.98M
--7.75M
72.71%50.49M
64.99%48.24M
Goodwill
-17.02%178.48M
-17.02%178.48M
-47.96%178.48M
702.42%178.48M
867.07%215.1M
867.07%215.1M
1,441.92%342.96M
0.00%22.24M
-3.54%22.24M
-3.54%22.24M
Long deferred expense
-13.80%18.86M
-3.74%20.84M
12.31%23.45M
4.18%24.04M
-3.02%21.88M
-15.07%21.65M
-7.11%20.87M
-11.83%23.08M
-63.49%22.57M
-33.56%25.5M
Deferred tax assets
101.40%92.26M
172.55%74.66M
72.12%74.12M
84.56%72.18M
154.77%45.81M
49.64%27.39M
115.31%43.06M
143.58%39.11M
64.94%17.98M
62.78%18.31M
Usufruct assets
5.35%608.22M
13.07%631.36M
16.12%652.15M
14.91%623.65M
15.81%577.34M
18.20%558.38M
15.15%561.64M
10.90%542.71M
21.81%498.52M
25.61%472.42M
Other non current assets
-30.29%29.23M
-57.13%17.97M
-99.20%269.78K
-58.77%19.34M
--41.93M
--41.92M
--33.69M
3,561.01%46.9M
----
----
Total non current assets
1.98%7.81B
2.96%7.75B
5.76%7.81B
11.84%7.79B
12.32%7.65B
11.09%7.53B
11.83%7.38B
6.73%6.97B
10.45%6.82B
16.82%6.78B
Total assets
1.84%16.92B
-10.05%16.65B
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
Liabilities
Current liabilities
Short term loan
129.68%2.54B
1.60%2.7B
-16.66%3.18B
3.26%3.32B
-64.90%1.1B
-17.96%2.65B
0.28%3.82B
-19.75%3.21B
18.53%3.15B
51.15%3.23B
Notes payable and accounts payable
-4.16%612.29M
6.27%580.5M
25.42%653.57M
14.07%697.12M
23.17%638.84M
26.31%546.26M
-7.61%521.13M
31.36%611.11M
7.44%518.67M
-13.99%432.48M
-Notes payable
76.47%14.85M
463.86%23.79M
--21.08M
--5.3M
--8.41M
--4.22M
----
----
----
----
-Accounts payable
-5.23%597.44M
2.71%556.71M
21.37%632.49M
13.21%691.82M
21.55%630.42M
25.33%542.04M
-7.61%521.13M
31.36%611.11M
10.18%518.67M
-11.89%432.48M
Contract liabilities
112.15%735.34M
-32.28%498.67M
-1.51%481.41M
-6.82%440.23M
-33.47%346.61M
28.67%736.36M
-35.85%488.79M
-30.64%472.48M
24.38%520.94M
-35.03%572.29M
Advance receipts
----
----
----
-41.79%48.51K
----
----
----
-82.39%83.33K
----
----
Salaries payable
-4.07%233.7M
-11.65%220.16M
-14.11%267.63M
-5.01%297.56M
-12.82%243.63M
-11.12%249.18M
5.14%311.59M
-11.95%313.24M
-5.78%279.45M
-3.05%280.34M
Taxs payable
18.11%33.92M
-54.90%9.1M
66.33%40.72M
29.09%31.78M
172.86%28.72M
29.46%20.18M
-10.61%24.48M
32.71%24.62M
-57.41%10.53M
-66.18%15.59M
Other payable (including interest and dividends)
0.10%769.96M
-8.81%693.75M
-29.92%693.29M
-0.38%731.35M
5.82%769.22M
14.02%760.8M
77.35%989.22M
21.62%734.11M
34.57%726.93M
13.54%667.23M
-Dividend payable
----
----
----
----
----
0.00%48.3M
----
-85.94%2.92M
----
-17.42%48.3M
-Other payable
----
-2.63%693.75M
----
----
----
15.12%712.5M
----
25.45%731.19M
----
16.97%618.93M
Non current liabilities due within one year
-52.08%1.09B
4.99%1.6B
57.44%1.71B
104.82%1.49B
277.40%2.27B
102.89%1.53B
93.94%1.08B
-2.00%726.68M
-20.48%602.73M
19.10%752.09M
Other current liabilities
148.26%150.54M
-19.90%64.23M
-15.17%66.01M
-23.21%81.31M
-8.18%60.64M
20.84%80.2M
0.57%77.81M
17.06%105.9M
20.47%66.04M
-4.71%66.37M
Total current liabilities
12.73%6.16B
-3.16%6.36B
-3.00%7.1B
14.16%7.09B
-7.12%5.47B
8.98%6.57B
8.84%7.32B
-10.95%6.21B
12.52%5.89B
17.15%6.03B
Current liabilities
Long term loan
-7.55%1.64B
-41.99%1.48B
-45.79%1.56B
-60.89%1.23B
-38.60%1.77B
24.82%2.55B
27.68%2.88B
59.52%3.13B
44.20%2.89B
5.58%2.05B
Bonds payable
----
----
----
----
----
----
----
----
-4.72%90.71M
-4.55%91.23M
Deferred tax liabilities
7.65%17.82M
2,310.20%17.22M
2,374.31%17.68M
2,020.24%18.13M
4,135.14%16.55M
82.80%714.38K
82.80%714.38K
14.46%855.3K
-13.05%390.8K
-13.05%390.8K
Long term deferred income
29.47%141.35M
48.88%144.51M
60.50%144.54M
63.74%143.29M
30.71%109.17M
26.18%97.07M
17.40%90.06M
8.01%87.51M
1.46%83.52M
-10.05%76.93M
Lease liabilities
5.83%480.09M
32.60%494.54M
27.32%409.42M
19.96%362.93M
26.62%453.64M
6.28%372.97M
-5.91%321.55M
2.70%302.53M
9.88%358.27M
35.03%350.93M
Total non current liabilities
-3.14%2.28B
-29.32%2.14B
-35.21%2.13B
-50.35%1.75B
-31.23%2.35B
17.89%3.02B
18.98%3.29B
44.72%3.52B
36.46%3.42B
7.82%2.56B
Total liabilities
7.95%8.44B
-11.40%8.5B
-13.00%9.23B
-9.20%8.84B
-15.98%7.82B
11.64%9.6B
11.79%10.61B
3.46%9.73B
20.28%9.31B
14.20%8.6B
Shareholders equity
Paid-in capital
0.76%1.37B
0.77%1.37B
0.79%1.37B
0.81%1.37B
0.05%1.36B
0.04%1.35B
0.04%1.35B
0.04%1.35B
25.83%1.35B
25.83%1.35B
Other equity instruments
----
----
----
----
-6.48%3.37M
-4.89%3.45M
-4.55%3.52M
-4.47%3.6M
-5.10%3.6M
-4.91%3.63M
Capital reserve funds
0.70%3.94B
0.75%3.94B
0.15%3.94B
2.60%3.94B
3.02%3.91B
18.49%3.91B
19.24%3.94B
16.34%3.84B
149.17%3.8B
118.01%3.3B
Surplus reserve funds
6.31%466.77M
6.31%466.77M
6.31%466.77M
6.31%466.77M
58.80%439.08M
58.80%439.08M
58.80%439.08M
59.69%439.08M
21.66%276.49M
21.66%276.49M
Retained profit
-22.38%1.11B
-44.74%823.8M
-72.26%635.46M
-74.39%581.39M
-42.16%1.43B
-29.79%1.49B
6.50%2.29B
4.73%2.27B
-10.32%2.48B
-33.61%2.12B
Other composite income
1,117.36%54.99M
-54.34%10.28M
-115.39%-1.74M
3,494.81%51.12M
120.59%4.52M
160.57%22.52M
112.70%11.27M
115.50%1.42M
-163.54%-21.94M
-332.78%-37.18M
Ordinary risk reserve funds
0.00%3.85M
0.00%3.85M
0.00%3.85M
0.00%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
35.11%3.46M
35.11%3.46M
Shareholders equity without minority interests
-2.91%6.95B
-8.51%6.61B
-20.25%6.41B
-19.01%6.41B
-9.38%7.15B
2.86%7.23B
14.83%8.04B
11.52%7.92B
40.14%7.89B
16.35%7.03B
Minority interests
-6.59%1.53B
-8.89%1.54B
-11.69%1.53B
-12.28%1.5B
-6.76%1.64B
178.21%1.69B
187.09%1.73B
170.08%1.71B
133.61%1.76B
-16.11%607.09M
Total shareholder equity
-3.60%8.48B
-8.58%8.15B
-18.73%7.94B
-17.81%7.91B
-8.90%8.8B
16.81%8.92B
28.48%9.77B
24.54%9.63B
51.18%9.66B
12.88%7.63B
Total liabilityies and equity
1.84%16.92B
-10.05%16.65B
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024 (Q6)Jun 30, 2024 (Q3)Mar 31, 2024 (FY)Dec 31, 2023 (Q9)Sep 30, 2023 (Q6)Jun 30, 2023 (Q3)Mar 31, 2023 (FY)Dec 31, 2022 (Q9)Sep 30, 2022 (Q6)Jun 30, 2022
Assets
Current assets
Money funds -5.06%3.65B -25.54%2.86B -31.02%2.68B -15.00%2.82B -35.08%3.84B 57.11%3.84B 67.53%3.89B -3.05%3.32B 96.68%5.92B 37.29%2.45B
Transactional financial assets --10.55M -99.48%522.51K --472.63K -99.93%473.08K ---- --100M ---- --650.94M ---- ----
Notes receivable and accounts receivable -8.40%749.25M -16.17%613.5M -3.53%712.26M 7.93%430.75M 7.39%817.99M 33.91%731.84M 27.87%738.31M 26.94%399.1M 35.20%761.72M 17.61%546.5M
-Notes receivable 348.98%73.9M -32.03%13.47M 67.52%26.64M -11.60%9.62M 654.60%16.46M 306.30%19.82M 6.78%15.9M 30.07%10.88M -79.03%2.18M 11.89%4.88M
-Accounts receivable -15.74%675.36M -15.73%600.02M -5.09%685.63M 8.48%421.13M 5.53%801.54M 31.46%712.02M 28.43%722.41M 26.86%388.22M 37.35%759.54M 17.67%541.62M
Other receivables (including interest and dividends) 5.62%371.11M -5.95%283.77M -16.98%256M -13.60%259.14M 3.05%351.37M -2.96%301.73M -17.93%308.36M -8.72%299.94M -14.27%340.97M -18.31%310.92M
-Other receivable ---- -5.95%283.77M ---- ---- ---- -2.96%301.73M ---- -8.72%299.94M ---- -18.31%310.92M
Advance payment 131.55%862.5M -20.41%316.22M -27.30%484.52M -65.96%386.57M -52.75%372.48M -23.27%397.31M -24.24%666.45M 42.71%1.14B 13.60%788.37M -23.40%517.77M
Inventories -7.40%3B -15.59%4.32B -30.13%4.74B -24.63%4.55B -17.73%3.24B -0.22%5.12B 16.73%6.78B 15.07%6.04B 30.87%3.93B 7.45%5.13B
Receivable financing --11.28M --2.29M ---- 397.94%13.53M ---- ---- ---- 1,371.03%2.72M ---- ----
Other current assets 24.20%414.37M 2.55%483.24M -19.20%479.93M -11.04%475.88M -17.10%333.62M -4.24%471.21M 14.09%593.93M 7.35%534.95M 44.55%402.43M 35.72%492.07M
Total current assets 1.71%9.12B -18.97%8.9B -27.97%9.36B -27.71%8.96B -26.23%8.96B 16.21%10.98B 23.87%12.99B 16.81%12.4B 52.71%12.15B 11.36%9.45B
Non Current assets
Long-term equity investment -13.59%33.56M -12.16%33.83M 74.83%37.34M -65.76%36.11M -70.76%38.84M -69.39%38.51M -82.80%21.36M -2.43%105.45M 10.88%132.83M 10.53%125.8M
Fixed assets ---- 3.84%5.28B ---- ---- ---- 3.70%5.08B ---- 18.10%5.13B ---- 28.09%4.9B
Constru in process ---- 0.69%842.66M ---- ---- ---- 86.76%836.88M ---- -52.47%425.14M ---- -42.20%448.09M
Productive biological assets -22.75%280.75M -19.38%292.7M -22.07%295.55M -10.65%320.76M -5.62%363.42M -17.58%363.08M -7.13%379.26M 0.79%359M 14.20%385.07M 21.82%440.5M
Intangible assets 15.56%389.63M 13.12%385.71M 40.79%384.78M 34.44%360.84M 22.89%337.17M 22.06%340.96M -2.63%273.3M -1.36%268.4M 11.87%274.36M 11.73%279.34M
Development expenditure -65.10%3.16M -89.57%750K -52.15%6.21M -9.52%7.01M -82.06%9.06M -85.09%7.19M -55.59%12.98M --7.75M 72.71%50.49M 64.99%48.24M
Goodwill -17.02%178.48M -17.02%178.48M -47.96%178.48M 702.42%178.48M 867.07%215.1M 867.07%215.1M 1,441.92%342.96M 0.00%22.24M -3.54%22.24M -3.54%22.24M
Long deferred expense -13.80%18.86M -3.74%20.84M 12.31%23.45M 4.18%24.04M -3.02%21.88M -15.07%21.65M -7.11%20.87M -11.83%23.08M -63.49%22.57M -33.56%25.5M
Deferred tax assets 101.40%92.26M 172.55%74.66M 72.12%74.12M 84.56%72.18M 154.77%45.81M 49.64%27.39M 115.31%43.06M 143.58%39.11M 64.94%17.98M 62.78%18.31M
Usufruct assets 5.35%608.22M 13.07%631.36M 16.12%652.15M 14.91%623.65M 15.81%577.34M 18.20%558.38M 15.15%561.64M 10.90%542.71M 21.81%498.52M 25.61%472.42M
Other non current assets -30.29%29.23M -57.13%17.97M -99.20%269.78K -58.77%19.34M --41.93M --41.92M --33.69M 3,561.01%46.9M ---- ----
Total non current assets 1.98%7.81B 2.96%7.75B 5.76%7.81B 11.84%7.79B 12.32%7.65B 11.09%7.53B 11.83%7.38B 6.73%6.97B 10.45%6.82B 16.82%6.78B
Total assets 1.84%16.92B -10.05%16.65B -15.75%17.17B -13.48%16.75B -12.38%16.62B 14.07%18.51B 19.22%20.37B 12.97%19.36B 34.25%18.96B 13.58%16.23B
Liabilities
Current liabilities
Short term loan 129.68%2.54B 1.60%2.7B -16.66%3.18B 3.26%3.32B -64.90%1.1B -17.96%2.65B 0.28%3.82B -19.75%3.21B 18.53%3.15B 51.15%3.23B
Notes payable and accounts payable -4.16%612.29M 6.27%580.5M 25.42%653.57M 14.07%697.12M 23.17%638.84M 26.31%546.26M -7.61%521.13M 31.36%611.11M 7.44%518.67M -13.99%432.48M
-Notes payable 76.47%14.85M 463.86%23.79M --21.08M --5.3M --8.41M --4.22M ---- ---- ---- ----
-Accounts payable -5.23%597.44M 2.71%556.71M 21.37%632.49M 13.21%691.82M 21.55%630.42M 25.33%542.04M -7.61%521.13M 31.36%611.11M 10.18%518.67M -11.89%432.48M
Contract liabilities 112.15%735.34M -32.28%498.67M -1.51%481.41M -6.82%440.23M -33.47%346.61M 28.67%736.36M -35.85%488.79M -30.64%472.48M 24.38%520.94M -35.03%572.29M
Advance receipts ---- ---- ---- -41.79%48.51K ---- ---- ---- -82.39%83.33K ---- ----
Salaries payable -4.07%233.7M -11.65%220.16M -14.11%267.63M -5.01%297.56M -12.82%243.63M -11.12%249.18M 5.14%311.59M -11.95%313.24M -5.78%279.45M -3.05%280.34M
Taxs payable 18.11%33.92M -54.90%9.1M 66.33%40.72M 29.09%31.78M 172.86%28.72M 29.46%20.18M -10.61%24.48M 32.71%24.62M -57.41%10.53M -66.18%15.59M
Other payable (including interest and dividends) 0.10%769.96M -8.81%693.75M -29.92%693.29M -0.38%731.35M 5.82%769.22M 14.02%760.8M 77.35%989.22M 21.62%734.11M 34.57%726.93M 13.54%667.23M
-Dividend payable ---- ---- ---- ---- ---- 0.00%48.3M ---- -85.94%2.92M ---- -17.42%48.3M
-Other payable ---- -2.63%693.75M ---- ---- ---- 15.12%712.5M ---- 25.45%731.19M ---- 16.97%618.93M
Non current liabilities due within one year -52.08%1.09B 4.99%1.6B 57.44%1.71B 104.82%1.49B 277.40%2.27B 102.89%1.53B 93.94%1.08B -2.00%726.68M -20.48%602.73M 19.10%752.09M
Other current liabilities 148.26%150.54M -19.90%64.23M -15.17%66.01M -23.21%81.31M -8.18%60.64M 20.84%80.2M 0.57%77.81M 17.06%105.9M 20.47%66.04M -4.71%66.37M
Total current liabilities 12.73%6.16B -3.16%6.36B -3.00%7.1B 14.16%7.09B -7.12%5.47B 8.98%6.57B 8.84%7.32B -10.95%6.21B 12.52%5.89B 17.15%6.03B
Current liabilities
Long term loan -7.55%1.64B -41.99%1.48B -45.79%1.56B -60.89%1.23B -38.60%1.77B 24.82%2.55B 27.68%2.88B 59.52%3.13B 44.20%2.89B 5.58%2.05B
Bonds payable ---- ---- ---- ---- ---- ---- ---- ---- -4.72%90.71M -4.55%91.23M
Deferred tax liabilities 7.65%17.82M 2,310.20%17.22M 2,374.31%17.68M 2,020.24%18.13M 4,135.14%16.55M 82.80%714.38K 82.80%714.38K 14.46%855.3K -13.05%390.8K -13.05%390.8K
Long term deferred income 29.47%141.35M 48.88%144.51M 60.50%144.54M 63.74%143.29M 30.71%109.17M 26.18%97.07M 17.40%90.06M 8.01%87.51M 1.46%83.52M -10.05%76.93M
Lease liabilities 5.83%480.09M 32.60%494.54M 27.32%409.42M 19.96%362.93M 26.62%453.64M 6.28%372.97M -5.91%321.55M 2.70%302.53M 9.88%358.27M 35.03%350.93M
Total non current liabilities -3.14%2.28B -29.32%2.14B -35.21%2.13B -50.35%1.75B -31.23%2.35B 17.89%3.02B 18.98%3.29B 44.72%3.52B 36.46%3.42B 7.82%2.56B
Total liabilities 7.95%8.44B -11.40%8.5B -13.00%9.23B -9.20%8.84B -15.98%7.82B 11.64%9.6B 11.79%10.61B 3.46%9.73B 20.28%9.31B 14.20%8.6B
Shareholders equity
Paid-in capital 0.76%1.37B 0.77%1.37B 0.79%1.37B 0.81%1.37B 0.05%1.36B 0.04%1.35B 0.04%1.35B 0.04%1.35B 25.83%1.35B 25.83%1.35B
Other equity instruments ---- ---- ---- ---- -6.48%3.37M -4.89%3.45M -4.55%3.52M -4.47%3.6M -5.10%3.6M -4.91%3.63M
Capital reserve funds 0.70%3.94B 0.75%3.94B 0.15%3.94B 2.60%3.94B 3.02%3.91B 18.49%3.91B 19.24%3.94B 16.34%3.84B 149.17%3.8B 118.01%3.3B
Surplus reserve funds 6.31%466.77M 6.31%466.77M 6.31%466.77M 6.31%466.77M 58.80%439.08M 58.80%439.08M 58.80%439.08M 59.69%439.08M 21.66%276.49M 21.66%276.49M
Retained profit -22.38%1.11B -44.74%823.8M -72.26%635.46M -74.39%581.39M -42.16%1.43B -29.79%1.49B 6.50%2.29B 4.73%2.27B -10.32%2.48B -33.61%2.12B
Other composite income 1,117.36%54.99M -54.34%10.28M -115.39%-1.74M 3,494.81%51.12M 120.59%4.52M 160.57%22.52M 112.70%11.27M 115.50%1.42M -163.54%-21.94M -332.78%-37.18M
Ordinary risk reserve funds 0.00%3.85M 0.00%3.85M 0.00%3.85M 0.00%3.85M 11.53%3.85M 11.53%3.85M 11.53%3.85M 11.53%3.85M 35.11%3.46M 35.11%3.46M
Shareholders equity without minority interests -2.91%6.95B -8.51%6.61B -20.25%6.41B -19.01%6.41B -9.38%7.15B 2.86%7.23B 14.83%8.04B 11.52%7.92B 40.14%7.89B 16.35%7.03B
Minority interests -6.59%1.53B -8.89%1.54B -11.69%1.53B -12.28%1.5B -6.76%1.64B 178.21%1.69B 187.09%1.73B 170.08%1.71B 133.61%1.76B -16.11%607.09M
Total shareholder equity -3.60%8.48B -8.58%8.15B -18.73%7.94B -17.81%7.91B -8.90%8.8B 16.81%8.92B 28.48%9.77B 24.54%9.63B 51.18%9.66B 12.88%7.63B
Total liabilityies and equity 1.84%16.92B -10.05%16.65B -15.75%17.17B -13.48%16.75B -12.38%16.62B 14.07%18.51B 19.22%20.37B 12.97%19.36B 34.25%18.96B 13.58%16.23B
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007)
Audit Opinions -- -- -- Unqualified opinion -- -- -- Unqualified opinion -- --
Auditor -- -- -- Sigma Certified Public Accountants (Special General Partnership) -- -- -- Sigma Certified Public Accountants (Special General Partnership) -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data